Latest News

Drug overdose deaths down since late 2017


 

Overall drug overdose deaths may have peaked at the end of last year, as the most recent data show a drop of almost 3% in 12-month ending counts from November 2017 to March 2018, according to the National Center for Health Statistics.

Change in drug overdose deaths for 12-month ending periods

Longer-term data, however, show an increase over the year from March 2017 to March 2018, as the short-term decrease was not enough to overcome the previous year’s increase. The provisional 12-month ending count – deaths during the 12-month period ending in the month indicated – went from 66,859 in March 2017 to 68,690 in March 2018, an increase of 2.7%, the NCHS reported.

That year-long increase was not spread evenly among the states. Nebraska’s 12-month ending count jumped over 48% from March 2017 to March 2018, more than twice as much as second-place Hawaii’s 20.9%. Montana had the largest drop over that year, –24.2%, with Wyoming next at –20.7% and the District of Columbia third at –14.8%, data from the National Vital Statistics System show.

“Provisional drug overdose death data are often incomplete,” the NCHS noted, “and the degree of completeness varies by jurisdiction and 12-month ending period. Consequently, the numbers of drug overdose deaths are underestimated, based on provisional data relative to final data and are subject to random variation.”

Recommended Reading

Inpatient vs. outpatient addiction treatment: Which is best?
MDedge Internal Medicine
FDA issues new REMS for immediate-release opioids
MDedge Internal Medicine
Confirmed: Growth in overdose deaths is exponential
MDedge Internal Medicine
Transition to noninjected drug use lowers risk of HCV infection
MDedge Internal Medicine
House, Senate agree on broad opioid legislation
MDedge Internal Medicine
Opioid use in OA may mean more activity-limiting pain
MDedge Internal Medicine
Opiate use tied to hepatitis C risk in youth
MDedge Internal Medicine
Beyond the opioids
MDedge Internal Medicine
Book Review: DuPont’s approach to addiction is tough, yet compassionate
MDedge Internal Medicine
XR-naltrexone beats oral medication for opioid use disorder
MDedge Internal Medicine